After receiving the report, director James D. Coffey told Colorado officials that the Board of Registration in Pharmacy would "respond as soon as possible following a thorough analysis of (the report)."
For 35 years, The Washington Times has produced in-depth, award-winning reporting and hard-hitting commentary from the nation's capital. Presidents change and lawmakers come and go, but The Times is always here, and FREE online. We appreciate your loyalty. Please support our efforts.